Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,713
Closed -$1.04M 53
2025
Q3
$1.04M Buy
3,713
+6
+0.2% +$1.53K 0.16% 48
2025
Q2
$811K Buy
3,707
+209
+6% +$33.7K 0.12% 53
2025
Q1
$489K Sell
3,498
-323
-8% -$52.6K 0.08% 55
2024
Q4
$637K Sell
3,821
-118
-3% -$21K 0.1% 50
2024
Q3
$671K Hold
3,939
0.1% 54
2024
Q2
$556K Sell
3,939
-3,550
-47% -$441K 0.09% 54
2024
Q1
$941K Hold
7,489
0.16% 47
2023
Q4
$790K Hold
7,489
0.13% 49
2023
Q3
$793K Hold
7,489
0.15% 48
2023
Q2
$892K Sell
7,489
-76
-1% -$7.86K 0.17% 48
2023
Q1
$703K Sell
7,565
-266
-3% -$23.3K 0.14% 49
2022
Q4
$640K Sell
7,831
-45
-0.6% -$3.42K 0.14% 52
2022
Q3
$481K Sell
7,876
-2,665
-25% -$195K 0.11% 53
2022
Q2
$736K Buy
10,541
+11
+0.1% +$805 0.16% 47
2022
Q1
$871K Sell
10,530
-50
-0.5% -$4.05K 0.19% 48
2021
Q4
$923K Buy
10,580
+2,684
+34% +$252K 0.16% 51
2021
Q3
$688K Sell
7,896
-2,740
-26% -$242K 0.14% 51
2021
Q2
$828K Buy
+10,636
New +$833K 0.18% 39

Other funds holding ORCL

McMorgan & Co's ORCL Position: Q4 2025 in Review

McMorgan & Co sold out of Oracle (ORCL) in Q4 2025, closing a stake of 3,713 shares — an estimated $1.04M sold.

McMorgan & Co first reported a position in ORCL in Q2 2021 and held it in 18 quarters. The position peaked at $1.04M in Q3 2025. 3,770 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

  • McMorgan & Co reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
  • McMorgan & Co sold 3,713 Oracle shares in Q4 2025, an estimated $1.04M.
  • McMorgan & Co first reported a position in Oracle in Q2 2021 and held it in 18 quarters.
  • McMorgan & Co's Oracle position peaked at $1.04M in Q3 2025.
  • 3,770 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on McMorgan & Co's 13F filing for Q4 2025, filed 11 Feb 2026.